tirzepatide age approval FDA Grants a New Indication for Obesity Management Tirzepatide leads to weight reduction

Its mild action helps reveal fresher, smoother skin without harsh scrubbing

NICE now recommends SGLT2 inhibitors as first-line therapy for people with established or high risk of cardiovascular disease, heart failure, or chronic kidney disease

Heres whats behind this side effect, plus what to do if youre struggling with it

In the US, the FDA classifies these compounds as research chemicals when sold and labeled for laboratory use and not for human consumption

Christopher McGowan, a gastroenterologist who runs a weight loss clinic in North Carolina, said one issue he has had with using LillyDirect is supply

Trigiani et al., 2018